Key Rating Drivers & Detailed Description
Strengths:
* Strategic importance to, and expectation of strong support from, GoI
United India Insurance is likely to receive strong government support on a steady state basis, driven by its established track record and extensive market reach which make the company strategically important to GoI. The importance of the general insurance sector, especially government-owned insurers such as United India Insurance, can also be perceived from the government plan to materially enhance insurance penetration in the long term. As a demonstration of their strategic importance to the government and the latter’s stance on extending timely support, public general insurers were allotted Rs 12,450 crore of capital by the government in July 2020 (including the Rs 2,500 crore already infused in March 2020). United India Insurance, National Insurance Company Ltd (National) and The Oriental Insurance Company (Oriental) cumulatively received Rs 2,500 crore in fiscal 2020 and Rs 9,950 crore in fiscal 2021. Of this, United India Insurance received Rs 50 crore and Rs 3,605 crore, respectively. In the fourth quarter of fiscal 2022, the three PSUs received Rs 5,000 crore from the government, of which Rs 3,700 crore was infused in National, Rs 1200 crore in Oriental and Rs 100 crore in United India Insurance.
Along with the capital allocation, the government also announced its decision to shelve the merger of United India Insurance with National and Oriental and to focus on improving the standalone financial risk profiles of these entities. CRISIL Ratings has noted the government plan announced in the last annual budget to privatise one of the public general insurers in the long term, and will continue to monitor developments in this aspect.
* Established market position
United India Insurance is the third-largest general insurance company in India with a market share of 7.1% based on gross premiums originated during fiscal 2022. The company underwrote gross premium of Rs 15,721 crore in fiscal 2022, down 5.9% on-year against industry growth of 11%. This reduction stemmed from negative growth in key segments such as motor and the company’s decision to stop crop insurance. In line with the trend observed for most of its peers and the sector as a whole, continued traction in health insurance post Covid has been the key driver. Apart from health insurance which has outgrown motor to become the largest portfolio for United India Insurance, niche segments such as fire, engineering, marine, liability and aviation have also grown.
While on one hand, Covid has affected the underwriting performance for the industry, on the other, it has helped increase awareness particularly for health insurance products. The growth in health insurance portfolio is expected to correct marginally in fiscal 2023 and stabilise thereafter. An upward revision in pricing of health products is expected which will also contribute to the correction. New business and renewal premium for larger segments such as motor insurance may witness some traction as the impact of Covid-19 on the claims performance starts to fade. Tariff rates may be hiked in the third-party segment, which was absent for over two years. However, with increasing ticket size of non-Covid-19 claims, the impact of actual losses borne by the insurers after the second wave on their underwriting performance and capital and solvency position remains to be seen.
Weakness:
* Reported solvency remains below regulatory stipulation and capitalisation dependent on equity infusion by the government
Capitalisation and solvency position of United India Insurance remain strained. Reported solvency ratio, excluding the balance in fair value change account, has been below 1.5 times for over 12 quarters now. However, IRDAI’s exceptional approval has allowed the company (along with National and Oriental) to include the fair value change account balance in the available solvency margin for calculating solvency. Resultantly, on March 31, 2021, the company reported a solvency ratio of 1.41 time (factoring in 65% of the balance in fair value change account; excluding the fair value change account balance, the solvency ratio was 1.0 times). Subsequently, the company’s underwriting performance and profitability weakened on account of the surge in Covid claims during the first half of fiscal 2022 which resulted in a sharp decline in the solvency ratio to 0.72 time (excluding balance in fair value change account). Upon including the balance in fair value change account as of that date, the solvency ratio is estimated to have been 1.53 times. Negative accrual pulled networth down to Rs 2,936 crore as on December 31, 2021, from Rs 4,130 crore as on March 31, 2021. The company received equity infusion of Rs 100 crore during the fourth quarter of fiscal 2022, which may improve the solvency margin marginally.
Nonetheless, capitalisation and solvency position will remain dependent on equity support from the government and the fair value change balance over the medium term. Regulatory relaxations allowed by the government to the company may provide some support, in terms of including fair value change balance in solvency reporting. The company aims to restore its solvency position to 1.5 times (excluding fair value change balance) over the next 5-6 quarters. In the meantime, delay in improvement in underwriting performance and profitability, thereby significantly impacting capital and solvency position, will remain a key rating sensitivity factor.
* Modest underwriting performance
Underwriting performance had moderated after fiscal 2017 because of additional provisioning requirement in the motor third party segment. After fiscal 2017, however, underwriting performance had improved momentarily in fiscal 2018; however, it has remained weak since then. For fiscal 2021, the company reported an underwriting deficit of Rs 3,218 crore compared to a Rs 4,398 deficit in fiscal 2020. correspondingly, The combined ratio stood at 122.7% from 132% For the nine months ended December 31, 2021, underwriting deficit stood at Rs 3,062 crore as compared to Rs 2,263 crore for the corresponding period previous fiscal. Combined ratio for the nine months of fiscal 2022 stood at 132.7% as compared to 122.7% in the corresponding period in fiscal 2021 - driven by increase instances of claims due to second wave of covid.
Around 10% of the total claims (Rs 1,346 crore) till February 28, 2022, comprised Covid claims. Majority of the claims in the first nine months of fiscal 2022 were reported in the first half of the fiscal; the number of Covid claims declined thereafter as the second wave of the pandemic subsided. However, any deterioration in the company’s underwriting performance, further constraining its earnings and capitalisation, will be a key rating sensitivity factor.
* Weak earning putting pressure on capital position
Earnings remain weak, constrained by modest underwriting performance and inadequate, though stable, investment income. Despite investment income of Rs 2,799 crore for fiscal 2021, the company reported a net loss of Rs 985 crore, against a loss of Rs 1,486 crore in the previous fiscal. For the nine months of fiscal 2022, the company earned Rs 2,149 crore from investments compared to Rs 2,077 crore earned in the corresponding period of the previous fiscal. With underwriting loss of Rs 3,062 crore, net loss for the first nine months of fiscal 2022 was Rs 1,194 crore against Rs 452 crore for the corresponding period of fiscal 2021. Ability to improve underwriting performance such that overall profitability is revived and capital position and solvency are sustained at strong levels, will remain a key monitorable.